Researchers predict a steady increase in fatty liver disease in the U.S. population, but there's not a lot of treatment options available.

This can slow the progression of MASH and improve overall liver health. “It’s a very attractive mechanism,” Dr. Gunn says. “It also has some ability to lower LDL [“bad”] cholesterol ...

The result suggests that the protein made by the gene, known as Nwd1, and other molecules it interacts with could be worthwhile targets for new MASH therapies. The scientists published their work ...

MASH is marked by lipid droplet accumulation in ... Our research is the first to explore the role of Nwd1 outside of the brain,” says Dr. Sakakibara. The first co-author, Dr. Seiya Yamada ...